International Stem Cell Corporation Announces Second Patient with Parkinson’s Disease Treated in Phase I Clinical Trial
International Stem Cell Corporation to Present Results of Neural Stem Cell Transplantation for Parkinson’s Disease
International Stem Cell Corporation and Rohto Pharmaceutical Enter Second Stage of Research Agreement
Premier American Uranium Reports Results Following Annual General and Special Meeting of Shareholders
Nuvau Winter Drilling at Thundermine Returns 5.28 g/t Au over 6.1 m, Including 7.22 g/t Au over 3.1 m
